AMY PUSATERI: Open Payments
NPI 1265062574 · SCRANTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$809 in 57 payments from 12 companies in 2025. Trend: 2023 $79 · 2024 $410 · 2025 $809
Food & beverage: $700Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 28 | $353 |
| Janssen Pharmaceuticals, Inc | 13 | $172 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| ABBVIE INC. | 3 | $47 |
| Neurocrine BioSciences, Inc. | 2 | $29 |
| Alkermes, Inc. | 1 | $23 |
| Almatica Pharma LLC | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Lundbeck LLC | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: UZEDY, INVEGA SUSTENNA, REXULTI, SPRAVATO, VRAYLAR, AUSTEDO XR, INGREZZA, ARISTADA.
Industry payments across PA — which companies pay providers there.
